Nachrichten zur Merck KGaA Aktie

Should You Buy the Dip on This High-Flying Stock?

Its been an excellent year for Viking Therapeutics (NASDAQ: VKTX), a mid-cap biotech company. Thanks to impressive mid-stage clinical results,…

Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on It

Recently, Zacks.com users have been paying close attention to Merck (MRK). This makes it worthwhile to examine what the stock…

Want $2,000 in Annual Dividends? Invest $11,000 in Each of These 3 Stocks.

Investing in dividend stocks can be an excellent way to boost your income each year. But the challenge can be…

2 High-Yield Dividend Stocks to Buy Early in 2025

The healthcare sector has long been a sanctuary for income investors seeking stability and growth. Within this realm, Bristol-Myers Squibb…

Will This Major Pharmaceutical Stock Announce a Stock Split in 2025?

Stocks splits have been a huge market theme in 2024, with big names across industries, from technology giant Nvidia to…

3 Stocks That Could Be Monster Winners in 2025

What do many kids like most about the coming of a new year? The fireworks. Investors dont mind seeing some…

These stocks will be the biggest Dow winners of 2025, according to analysts

Some favorites of the Dow Jones Industrial Average, including Nvidia and Merck, could surge next year.…

2 Reasons to Sell Merck Stock and 1 Reason to Buy

There is plenty to like about Merck (NYSE: MRK). It is one of the largest pharmaceutical companies and the owner…

Merck - Selten so attraktiv

Mit strategischen Zukäufen treibt die deutsche Merck ihr geplantes Wachstum zielgerichtet voran. Die Anleger zeigen sich zuletzt aber skeptisch -…

Is Merck the Next Big Weight-Loss Stock?

Watch out, Eli Lilly and Novo Nordisk. Merck (NYSE: MRK) is hungrily looking to take a bite out of the…

Is Recursion Pharmaceuticals Stock a Millionaire Maker?

Successfully navigating the stock market requires patience and a long-term perspective. The key is sticking to a consistent plan and…

Down 18% in 1 Day, Is Viking Therapeutics Stock in Trouble Due to Merck?

The weight-loss biotech Viking Therapeutics (NASDAQ: VKTX) saw its stock get absolutely slammed on Dec. 18, falling 18% as a…

Merck Aktie: Aussichten trüb

Die Merck KGaA verzeichnet in den letzten Handelstagen des Jahres 2024 eine deutliche Abwärtsbewegung an der Frankfurter Börse. Der Pharma-…

Why Viking Therapeutics Tumbled by More Than 10% This Week

News of a fresh licensing deal by a well-capitalized rival sent Viking Therapeutics (NASDAQ: VKTX) stock into something of a…

BMO cuts rating on Merck and Biogen, on lack of near term catalyst By Investing.com

BMO cuts rating on Merck and Biogen, on lack of near term catalyst…

Investing in Merck (NYSE:MRK) three years ago would have delivered you a 43% gain

It hasnt been the best quarter for Merck & Co., Inc. ( NYSE:MRK ) shareholders, since the share price has…

Want to Collect a Dividend Every Month? Invest in These 3 High-Yielding Income Stocks

Collecting dividend income on a recurring basis can help strengthen your financial position and be a way for you to…

Is Moderna Stock a Buy?

Modernas (NASDAQ: MRNA) wild success in the COVID-19 vaccine market has worn off. The companys revenue, earnings, and stock price…

Where Will Summit Therapeutics Be in 5 Years?

Summit Therapeutics (NASDAQ: SMMT) has risen in prominence in the past two years thanks to a promising pipeline candidate, ivonescimab,…

3 Stocks That Could Turn $1,000 into $5,000 by 2030

A five-bagger in only five years? Any investor would love to buy such a stock. Fortunes can be made quickly…

MRKs Pivotal Study on Two-Drug, Once-Daily HIV Pill Meets Goals

Merck posts positive data from two phase III studies evaluating a two-drug, single-tablet regimen of doravirine/islatravir in adults with HIV-1…

Mercks HIV treatment meets main goal of two late-stage studies By Reuters

Mercks HIV treatment meets main goal of two late-stage studies…

Merck Enters Obesity Space, Buys Rights to Hansohs Oral GLP-1 Drug

Merck gets exclusive global rights to develop, manufacture and commercialize GLP-1 receptor agonist, HS-10535, from Hansoh Pharma.…

Opening Bell: Dow Jones steigt vor Zinsentscheid; Nvidia, Rigetti, IBM, D-Wave, Merck, Unitedhealth im Fokus

Am US-Aktienmarkt zeichnen sich am Mittwoch zum Handelsstart moderate Gewinne ab. Im Fokus steht die Leitzinsentscheidung zwei Stunden vor Börsenschluss…

Pharmaindustrie: Merck sichert sich Rechte an Abnehmpille in Milliardendeal

Der Pharmakonzern hat eine Lizenzvereinbarung mit dem chinesischem Biotech-Unternehmen Hansoh geschlossen. Merck darf künftig die Abnehmpille der Chinesen vermarkten und…

Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal

Merck will pay Hansoh $112 million upfront for rights to the drug, with the potential for an additional $1.9 billion…

Merck pens $2bn deal for obesity drug from China’s Hansoh

Merck & Co Inc (NYSE:MRK, ETR:6MK) has sought a potential weight loss drug candidate through a deal worth up to…

3 No-Brainer Biotech Stocks to Buy With $200 Right Now

Investing in biotech stocks usually isnt for the faint of heart. These stocks tend to be highly volatile because of…

DAX vor Fed-Entscheid leichter – Ceconomy, Commerzbank, Daimler Truck, Infineon, Kontron, Mercedes-Benz, Merck, MTU, Pro7, Redcare im Check

Vor der wichtigen Notenbanksitzung heute Abend halten sich die deutschen Anleger zurück. Der DAX hat den Handel am Dienstag bei…

DAX vor Fed-Entscheid leichter – Ceconomy, Commerzbank, Daimler Truck, Infineon, Kontron, Mercedes-Benz, Merck, MTU, Pro7, Redcare im Check

Vor der wichtigen Notenbanksitzung heute Abend halten sich die deutschen Anleger zurück. Der DAX hat den Handel am Dienstag bei…

Mercks BLA for RSV Antibody Clesrovimab Gets FDA Acceptance

The FDA accepts MRKs BLA for clesrovimab, its monoclonal antibody, to protect infants from RSV disease. A decision from the…

Merck übernimmt Spezialisten für Zellkulturmodelle

DARMSTADT (dpa-AFX) - Der Darmstädter Pharma- und Technologiekonzern Merck stärkt sein Geschäft mit einer weiteren Übernahme. Der Dax -Konzern…

Merck übernimmt Spezialisten für Zellkulturmodelle

DARMSTADT (dpa-AFX) - Der Darmstädter Pharma- und Technologiekonzern Merck stärkt sein Geschäft mit einer weiteren…

Merck übernimmt Spezialisten für Zellkulturmodelle

DARMSTADT (dpa-AFX) - Der Darmstädter Pharma- und Technologiekonzern Merck stärkt sein Geschäft mit einer weiteren Übernahme. Der DAX-Konzern kauft das…

Merck: Buy Opportunity Backed By Growth

…

Merck ends development of two antibody programs

…

Merck Has Become Very Cheap Again

…

2 Soaring Stocks That Could Climb 68% to 166% Higher in 2025, According to Wall Street

Its been a good year for the stock market as a whole and a tremendous year for a couple of…

Investing $5,000 in Each of These 3 Stocks at the Start of 2024 Would Have Created a Portfolio Worth More Than $100,000 Today

Normally, you might expect to achieve significant gains from stocks if you invest in them for years, perhaps decades. But…

dpa-AFX ProFeed